Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
the actual benefit of CERVARIX remains substantial only the Marketing Authorisation indications recommended by the HCSP in the current vaccination schedule. |
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
QJcjWuwjk39NDMwx
